$CXXIF
C21 Investments Inc. Stock $cxxif

$cxxif Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 20-F Financial Statement

#000106299324014658 Filed on August 08, 2024

Income Statement

Concept	2024 Q1
Revenue	$4.465M
YoY Change	-36.51%
Cost Of Revenue	$2.689M
YoY Change	-50.05%
Gross Profit	$1.776M
YoY Change	7.66%
Gross Profit Margin	39.78%
Selling, General & Admin	$1.486M
YoY Change	-23.71%
% of Gross Profit	83.68%
Research & Development	$2.465K
YoY Change
% of Gross Profit	0.14%
Depreciation & Amortization	$207.2K
YoY Change	-55.2%
% of Gross Profit	11.67%
Operating Expenses	$1.489M
YoY Change	-34.96%
Operating Profit	$289.9K
YoY Change	-145.35%
Interest Expense	$0.00
YoY Change	-100.0%
% of Operating Profit	0.0%
Other Income/Expense, Net	$8.440K
YoY Change	-145.09%
Pretax Income	$321.3K
YoY Change	-143.82%
Income Tax	$372.7K
% Of Pretax Income	116.01%
Net Earnings	-$74.40K
YoY Change	-96.49%
Net Earnings / Revenue	-1.67%
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00
COMMON SHARES
Basic Shares Outstanding	120.0M
Diluted Shares Outstanding	122.9M

Balance Sheet

Concept	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.409M
YoY Change	27.32%
Cash & Equivalents	$2.409M
Short-Term Investments
Other Short-Term Assets	$1.922M
YoY Change	-15.13%
Inventory	$2.709M
Prepaid Expenses
Receivables	$189.2K
Other Receivables	$13.83K
Total Short-Term Assets	$7.242M
YoY Change	-17.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.433M
YoY Change	-73.73%
Goodwill	$28.54M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change	-100.0%
Total Long-Term Assets	$47.29M
YoY Change	-4.6%
TOTAL ASSETS
Total Short-Term Assets	$7.242M
Total Long-Term Assets	$47.29M
Total Assets	$54.53M
YoY Change	-6.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.188M
YoY Change	-51.6%
Accrued Expenses	$415.3K
YoY Change	-52.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$1.156M
YoY Change	-63.67%
Total Short-Term Liabilities	$14.17M
YoY Change	-5.4%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$9.301M
YoY Change	3.09%
Total Long-Term Liabilities	$9.301M
YoY Change	3.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.17M
Total Long-Term Liabilities	$9.301M
Total Liabilities	$23.48M
YoY Change	-2.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$72.78M
YoY Change	4.76%
Common Stock	$105.5M
YoY Change	0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.05M
YoY Change
Total Liabilities & Shareholders Equity	$54.53M
YoY Change	-6.49%

Cashflow Statement

Concept	2024 Q1
OPERATING ACTIVITIES
Net Income	-$74.40K
YoY Change	-96.49%
Depreciation, Depletion And Amortization	$207.2K
YoY Change	-55.2%
Cash From Operating Activities	$526.4K
YoY Change	-56.14%
INVESTING ACTIVITIES
Capital Expenditures	$51.48K
YoY Change	466.99%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$18.25K
YoY Change	101.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.39K
YoY Change	-99.29%
NET CHANGE
Cash From Operating Activities	526.4K
Cash From Investing Activities	-18.25K
Cash From Financing Activities	-11.39K
Net Change In Cash	$852.0K
YoY Change	-306.37%
FREE CASH FLOW
Cash From Operating Activities	$526.4K
Capital Expenditures	$51.48K
Free Cash Flow	$474.9K
YoY Change	-60.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	C21 Investments Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Z4
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Vancouver,
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	V6E 3H4
CY2024Q1	dei	Security12b Title Security12bTitle	Common shares, no par value
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	120047814
CY2024Q1	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024Q1	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3390933	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3433094	usd
CY2024Q1	cxxif	Right Of Use Asset Current RightOfUseAssetCurrent	8746825	usd
CY2024Q1	cxxif	Right Of Use Asset Current RightOfUseAssetCurrent	8829298	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9192588	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	121843	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2024Q1	us-gaap	Assets Assets	55225836	usd
CY2024Q1	us-gaap	Assets Assets	54528934	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9120396	usd
CY2024Q1	us-gaap	Liabilities Liabilities	23481926	usd
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	628141	usd
CY2024Q1	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	628141	usd
CY2024Q1	us-gaap	Revenues Revenues	4464950	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2024	us-gaap	Interest Expense InterestExpense	35210	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	321304	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258657	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372743	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3482125	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-51439	usd
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-22965	usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-81817	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3223468	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
CY2024	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	35210	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	22128	usd
CY2024	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-451372	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	51370	usd
CY2024	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-209289	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	74639	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1948095	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-158526	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-130489	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	904620	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3261255	usd
CY2024Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	6861	usd
CY2024	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	68599	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2026667	usd
CY2024Q1	cxxif	Interest Paid In Cash InterestPaidInCash	0	usd
CY2024	cxxif	Interest Paid In Cash InterestPaidInCash	51562	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	0	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2653365	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1891772	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3260568	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2408526	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	51562	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	0	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1549425	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1421541	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1136096	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1139116	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	180533	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1955197	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1861553	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3390933	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3433094	usd
CY2024	us-gaap	Depreciation Depreciation	559712	usd
CY2024Q1	cxxif	Depreciation And Amortization Expense Allocated To Inventory DepreciationAndAmortizationExpenseAllocatedToInventory	81301	usd
CY2024	cxxif	Depreciation And Amortization Expense Allocated To Inventory DepreciationAndAmortizationExpenseAllocatedToInventory	474172	usd
CY2024Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	12010274	usd
CY2024Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	12010274	usd
CY2024Q1	cxxif	Finite Lived Brands Gross FiniteLivedBrandsGross	644800	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14195521	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7908931	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7712656	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	196275	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1456637	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1188133	usd
CY2024Q1	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	0	usd
CY2024	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	35210	usd
CY2024Q1	us-gaap	Legal Fees LegalFees	110240	usd
CY2024	us-gaap	Legal Fees LegalFees	892733	usd
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	207225	usd
CY2024	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1408976	usd
CY2024Q1	cxxif	License Fees Taxes And Insurance LicenseFeesTaxesAndInsurance	241436	usd
CY2024	cxxif	License Fees Taxes And Insurance LicenseFeesTaxesAndInsurance	1603921	usd
CY2024Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	79579	usd
CY2024	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	384583	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	106283	usd
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	633840	usd
CY2024Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	45664	usd
CY2024	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	907918	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	65173	usd
CY2024	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	16523	usd
CY2024Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	12178	usd
CY2024	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	52214	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1486394	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9677738	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	249072	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258657	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	16068	usd
CY2024Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	132394	usd
CY2024Q1	cxxif	Deferred Tax Assets Non Capital Losses DeferredTaxAssetsNonCapitalLosses	5170743	usd
CY2024Q1	cxxif	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	82004	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6488554	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-15965	usd
CY2024	cxxif	Consulting Fees Paid To Director ConsultingFeesPaidToDirector	65000	usd
CY2024	cxxif	Salary Paid To Directors And Officers SalaryPaidToDirectorsAndOfficers	438162	usd
CY2024Q1	cxxif	Share Compensation For Directors And Officers ShareCompensationForDirectorsAndOfficers	0	usd
CY2024	cxxif	Share Compensation For Directors And Officers ShareCompensationForDirectorsAndOfficers	22128	usd
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0
CY2021Q1	us-gaap	Legal Fees LegalFees	68195	usd
CY2021Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1252	usd
CY2021Q1	cxxif	Statutory Prevailing Party Fee StatutoryPrevailingPartyFee	640	usd
CY2019Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2774177	usd
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000831609
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024Q1	dei	Document Annual Report DocumentAnnualReport	true
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	751139	usd
CY2024Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	1164696	usd
CY2024Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	1170947	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	8138322	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	7242354	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6286590	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6482865	usd
CY2024Q1	us-gaap	Goodwill Goodwill	28541323	usd
CY2024Q1	us-gaap	Goodwill Goodwill	28541323	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2593195	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2215956	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1156259	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1156259	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	10230423	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	9719872	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	287560	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	301562	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	387400	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	374548	usd
CY2024Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	392320	usd
CY2024Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	396943	usd
CY2024Q1	cxxif	Current Deferred Tax Liabilities CurrentDeferredTaxLiabilities	0	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14165140	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120047814
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	9209	usd
CY2024	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-16451	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3223468	usd
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120047814
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120047814
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	34315076	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22128	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3290196	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-73596	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	30973412	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	82473	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	356631	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1034911	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	510551	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1983014	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-14002	usd
CY2024	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	207494	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-59340	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-310394	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	51483	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	521579	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-51483	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-121579	usd
CY2024Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2024	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2024	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-45551	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-365	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7395	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	852042	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	516754	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2408526	usd
CY2024Q1	cxxif	Working Capital Deficit WorkingCapitalDeficit	-6922786	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72776997	usd
CY2024Q1	cxxif	Sales Taxes Receivable SalesTaxesReceivable	13829	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	238023	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	189192	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	203021	usd
CY2024Q1	cxxif	Sales Taxes Receivable SalesTaxesReceivable	16368	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	148064	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2866054	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2708721	usd
CY2024Q1	us-gaap	Depreciation Depreciation	93644	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14195521	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1332507	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1323108	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1323108	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1323108	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	994158	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6286590	usd
CY2024Q1	us-gaap	Goodwill Goodwill	28541323	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	524058	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	415323	usd
CY2024Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	612500	usd
CY2024Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	612500	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2593195	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2215956	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	241678	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	1446208	usd
CY2024Q1	cxxif	Portion Of Operating Lease Costs Allocated To Inventory PortionOfOperatingLeaseCostsAllocatedToInventory	135395	usd
CY2024	cxxif	Portion Of Operating Lease Costs Allocated To Inventory PortionOfOperatingLeaseCostsAllocatedToInventory	812368	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y7M9D
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y9M7D
CY2024Q1	cxxif	Interest Payment In Cash InterestPaymentInCash	0	usd
CY2024	cxxif	Interest Payment In Cash InterestPaymentInCash	51562	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	8985939	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	15999875	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	9507796	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	387400	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9120396	usd
CY2024Q1	cxxif	Remaining Number Of Shares To Be Delivered RemainingNumberOfSharesToBeDelivered	1184407
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3240000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5615000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M12D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	600000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4810000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M9D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1100000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M17D
CY2024Q1	cxxif	Stock Options Outstanding And Exercisable Intrinsic Value StockOptionsOutstandingAndExercisableIntrinsicValue	0	usd
CY2024Q1	cxxif	Stock Options Outstanding And Exercisable Intrinsic Value StockOptionsOutstandingAndExercisableIntrinsicValue	0	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	22128	usd
CY2024	us-gaap	Professional Fees ProfessionalFees	522900	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	594570	usd
CY2024	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3156441	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21581	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	75561	usd
CY2024Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	0	usd
CY2024	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	22128	usd
CY2024Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	2465	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	12137758	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	12262392	usd
CY2024Q1	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	8035145	usd
CY2024Q1	cxxif	Consulting Fees Paid To Director ConsultingFeesPaidToDirector	30000	usd
CY2024Q1	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Leases AmountsPaidToCeoOrCompaniesControlledByCeoForLeases	126756	usd
CY2024	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Leases AmountsPaidToCeoOrCompaniesControlledByCeoForLeases	1001214	usd
CY2024Q1	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Repayments Of Promissory Note AmountsPaidToCeoOrCompaniesControlledByCeoForRepaymentsOfPromissoryNote	0	usd
CY2024	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Repayments Of Promissory Note AmountsPaidToCeoOrCompaniesControlledByCeoForRepaymentsOfPromissoryNote	2078229	usd
CY2024Q1	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Remuneration AmountsPaidToCeoOrCompaniesControlledByCeoForRemuneration	38462	usd
CY2024	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Remuneration AmountsPaidToCeoOrCompaniesControlledByCeoForRemuneration	200000	usd
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-22965	usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-81817	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120047814
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120047814
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2833093
CY2024	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2833093
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122880907
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122880907
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div> <div> <div> <div> <div> <div> <div> <p style="text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>20. CONTINGENCIES</strong></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">From time to time, the Company is involved in various litigation matters arising in the ordinary course of its business. Management is of the opinion that disposition of any current matter will not have a material adverse impact on the Company's financial position, results of operations, or the ability to carry on any of its business activities.</span></span></p> <div></div> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Legal proceedings </strong></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Oregon Action</strong>: A complaint was filed in the Oregon State Circuit Court for Clackamas County, on April 29, 2019, by two current owners of Proudest Monkey Holdings, LLC (the former sole member of EFF) (the "Plaintiffs"), alleging contract, employment, and statutory claims, alleging $612,500 in damages (as amended), against the Company, its wholly-owned subsidiaries 320204 US Holdings Corp, EFF, Swell Companies Limited, and Phantom Brands LLC, in addition to three directors, two officers, and one former employee (the "Oregon Action"). The Company and the other defendants wholly denied the allegations and claims made in the lawsuit and is defending the lawsuit. On June 21, 2019, the Company filed Oregon Rule of Civil Procedure ("ORCP") 21 motions to dismiss all of the Plaintiffs' claims against it, its wholly owned subsidiaries, and other defendants. On December 30, 2019, the Plaintiffs filed an amended complaint dismissing the Company (and some of its directors and subsidiaries) from the case and reducing the amount in controversy in the Oregon Action. On May 6, 2020, the court granted the Company's ORCP 21 motions in its entirety to dismiss all of Plaintiffs' claims against the remaining defendants. The judgment of dismissal was entered by the Clackamas County court on or about October 14, 2020.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 22, 2020, the Company submitted a petition to recover the costs and attorney fees incurred by the Company as the prevailing party in the Oregon Action. On January 20, 2021, the Court ruled in the Company's favor, awarding the Company and its subsidiaries $68,195 in attorney's fees, $1,252 in costs, and a statutory prevailing party fee of $640, through a supplemental judgment, entered on February 2, 2021. The judgment in favor of the Company remains unpaid and continues to collect interest at the statutory rate of 9% per annum.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 12, 2020, the Plaintiffs appealed the order dismissing the claims alleged in their amended complaint. On March 2, 2021, the Plaintiffs amended their appeal to appeal the award of attorney fees and costs.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 26, 2022, the Court of Appeals issued its decision, reversing the general and supplemental judgments in favor of the Company and remanding the case to the trial court for further proceedings. The Company filed a petition for reconsideration of the Court of Appeals decision on December 7, 2022, which was denied. On April 19, 2023, the Company filed a petition for review in the Oregon Supreme Court, which was denied. On November 1, 2023, the Court of Appeals issued the appellate judgement that reversed the October 2023 dismissal as well as the judgement for attorney fees and remanded the case against Phantom Brands, LLC, Swell Companies Limited, and two former employees. On December 21, 2023, the Plaintiffs filed a second amended complaint.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 2, 2024, the court confirmed dismissal of the Company and other defendants no longer named. The Company has filed a motion for costs and attorney fees totaling $108,876, with a hearing scheduled for July 29, 2024. Additionally, a settlement conference is set for October 22, 2024, and a twelve-person jury trial is scheduled for November 19, 2024.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>British Columbia Action</strong>: On or about September 13, 2019, the Company delivered a notice to the above-mentioned Plaintiffs of alleged breach and default under the EFF purchase and sale agreement, due to alleged unlawful, intentional acts and material misrepresentations by the Plaintiffs before and after the completion of the purchase. As a result of such breach, the Company denied the Plaintiffs' tender of their share payment notes in connection with the agreement. On or about October 14, 2019, Proudest Monkey Holdings, LLC and one of its current owners, sued the Company in the Supreme Court of British Columbia to compel the issuance and delivery of the subject shares, including interests and costs (the "British Columbia Action").</span></span></p> <p style="text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 8, 2019, the Company responded and counterclaimed for general, special and punitive damages, including interest and costs, related to breach of contract, repudiation of contract, breach of indemnity and fraudulent and negligent misrepresentation by the Plaintiffs. The Plaintiffs filed a response to the Company's counterclaims on or about June 5, 2020, and the parties stipulated to a form of amended pleading which included the joinder of additional parties, an owner of Proudest Monkey Holdings, LLC and EFF, and additional contract and equitable claims and damages, partially duplicative to those alleged by the Plaintiffs in the Oregon Action (breach of contract, indemnity, unjust enrichment and wrongful termination claims). Plaintiffs allege $2,774,177 in damages (as amended), plus unquantified additional damages, interest and costs, of which amounts are partially duplicative of the Oregon Action. This action remains in the discovery stage. The trial date was removed due to lack of prosecution by Plaintiffs. It is too early to predict the resolution of the claims and counterclaims.</span></span></p> </div> </div> </div> </div> </div> </div> </div>
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	510550	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3233053	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-137807	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372743	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3482125	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	321304	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	321304	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258657	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
CY2024Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	57498	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-74152	usd
CY2024Q1	cxxif	Effective Income Tax Rate Reconciliation Irc Section280 E Disallowance EffectiveIncomeTaxRateReconciliationIrcSection280EDisallowance	265584	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Irc Section280 E Disallowance EffectiveIncomeTaxRateReconciliationIrcSection280EDisallowance	1954392	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	5526	usd
CY2024Q1	cxxif	Effective Income Tax Rate Reconciliation Change In Foreign Exchange Rates And Other EffectiveIncomeTaxRateReconciliationChangeInForeignExchangeRatesAndOther	55019	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Change In Foreign Exchange Rates And Other EffectiveIncomeTaxRateReconciliationChangeInForeignExchangeRatesAndOther	21188	usd
CY2024Q1	cxxif	Effective Income Tax Rate Reconciliation Uncertain Tax Position Inclusive Of Interest And Penalties EffectiveIncomeTaxRateReconciliationUncertainTaxPositionInclusiveOfInterestAndPenalties	48080	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Uncertain Tax Position Inclusive Of Interest And Penalties EffectiveIncomeTaxRateReconciliationUncertainTaxPositionInclusiveOfInterestAndPenalties	-354637	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-671	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-50016	usd
CY2024Q1	cxxif	Effective Income Tax Rate Reconciliation Payable Adjustment To Provision Versus Statutory Tax Returns EffectiveIncomeTaxRateReconciliationPayableAdjustmentToProvisionVersusStatutoryTaxReturns	78204	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Payable Adjustment To Provision Versus Statutory Tax Returns EffectiveIncomeTaxRateReconciliationPayableAdjustmentToProvisionVersusStatutoryTaxReturns	1153756	usd
CY2024Q1	cxxif	Effective Income Tax Rate Reconciliation Deferred Adjustment To Provision Versus Statutory Tax Returns EffectiveIncomeTaxRateReconciliationDeferredAdjustmentToProvisionVersusStatutoryTaxReturns	-136497	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Deferred Adjustment To Provision Versus Statutory Tax Returns EffectiveIncomeTaxRateReconciliationDeferredAdjustmentToProvisionVersusStatutoryTaxReturns	824220	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372743	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3482125	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense		usd
CY2024Q1	cxxif	Deferred Tax Assets Share Issuance Costs And Financing Fees DeferredTaxAssetsShareIssuanceCostsAndFinancingFees	268	usd
CY2024Q1	cxxif	Deferred Tax Assets Share Issuance Costs And Financing Fees DeferredTaxAssetsShareIssuanceCostsAndFinancingFees	1610	usd
CY2024Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	131019	usd
CY2024Q1	cxxif	Deferred Tax Assets Non Capital Losses DeferredTaxAssetsNonCapitalLosses	5180776	usd
CY2024Q1	cxxif	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	80636	usd
CY2024Q1	cxxif	Deferred Tax Assets Rightof Use Assets And Lease Liabilities Net DeferredTaxAssetsRightofUseAssetsAndLeaseLiabilitiesNet	1032671	usd
CY2024Q1	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	22915	usd
CY2024Q1	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	29223	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6466306	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5260681	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1205625	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1227202	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	121843	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	3763	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	-91186	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Entity File Number EntityFileNumber	000-55982
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024Q1	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024Q1	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	us-gaap	Cash Cash	3260568	usd
CY2024Q1	us-gaap	Cash Cash	2408526	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	254391	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	203021	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2866054	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2708721	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15047157	usd
CY2024Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2024	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	503544	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-73596	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-51439	usd
CY2024	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	480340	usd
CY2024Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2024Q1	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	0	usd
CY2024	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	400000	usd
CY2024Q1	cxxif	Payments For Settlement Of Earn Out Shares PaymentsForSettlementOfEarnOutShares	0	usd
CY2024	cxxif	Payments For Settlement Of Earn Out Shares PaymentsForSettlementOfEarnOutShares	575136	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	1250150	usd
CY2024Q1	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	0	usd
CY2024	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	924105	usd
CY2024Q1	cxxif	Working Capital Deficit WorkingCapitalDeficit	-6908835	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="text-align:justify;margin-left:18pt;text-indent:-18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>a)</strong><span style="width:10pt;text-indent:0pt;display:inline-block"> </span><strong>Significant accounting estimates and assumptions</strong></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the Company's consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities and contingent liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and assumptions are continuously evaluated and are based on management's experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from those estimates and judgments.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Areas requiring a significant degree of estimation and judgment relate to the determination of recoverability of goodwill, recoverability of intangible assets, fair value less costs to sell of assets classified as held for sale, estimates used in valuation and costing of inventory, impairment of long-lived assets and inventory, fair value measurements, useful lives, depreciation and amortization of property, equipment and intangible assets, the recoverability and measurement of deferred tax assets and liabilities, share-based compensation, and fair value of derivative liability.</span></span></p> </div>
CY2024Q1	cxxif	Fdic Coverage Over Cash Balance FdicCoverageOverCashBalance	965157	usd
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2024Q1	cxxif	Working Capital Deficit WorkingCapitalDeficit	-6908835	usd
CY2024Q1	cxxif	Working Capital Deficit WorkingCapitalDeficit	-6922786	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	10230423	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372743	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	287560	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	301562	usd
CY2024Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	6861	usd
CY2024	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	68599	usd
CY2024Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-7591	usd
CY2024	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-45551	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	254391	usd
CY2024	cxxif	Cost Value Of Licenses Disposed CostValueOfLicensesDisposed	156750	usd
CY2024	cxxif	Accumulated Amortization Of Licenses Disposed AccumulatedAmortizationOfLicensesDisposed	85294	usd
CY2024Q1	cxxif	Amortization Of Intangible Assets Allocated To Inventory AmortizationOfIntangibleAssetsAllocatedToInventory	1393	usd
CY2024	cxxif	Amortization Of Intangible Assets Allocated To Inventory AmortizationOfIntangibleAssetsAllocatedToInventory	9071	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1323108	usd
CY2024Q1	us-gaap	Goodwill Goodwill	28541323	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	52474	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	70300	cad
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2189	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2933	cad
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1321107	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1360740	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1401562	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1443609	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6492080	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	15999875	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	16218421	usd
CY2024	cxxif	Obligation To Issue Shares Settled Number Of Shares ObligationToIssueSharesSettledNumberOfShares	4792800
CY2024	cxxif	Payments For Settlement Of Earn Out Shares PaymentsForSettlementOfEarnOutShares	575136	usd
CY2024Q1	cxxif	Remaining Earn Out Share Obligation RemainingEarnOutShareObligation	1207200
CY2018Q2	cxxif	Number Of Shares Issued To Vendors NumberOfSharesIssuedToVendors	1977500
CY2018Q2	cxxif	Value Of Shares Issued To Vendors ValueOfSharesIssuedToVendors	1905635	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2023	cxxif	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P2Y10D
CY2024Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	usd
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-8694	usd
CY2024Q1	cxxif	Deferred Tax Assets Goodwill DeferredTaxAssetsGoodwill	0	usd
CY2024Q1	cxxif	Deferred Tax Assets Goodwill DeferredTaxAssetsGoodwill	6606	usd
CY2024Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	4013	usd
CY2024Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3686	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	14008	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	14187	usd
CY2024Q1	cxxif	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	942784	usd
CY2024Q1	cxxif	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	959509	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	140998	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	283658	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1083782	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1243167	usd
CY2024Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-671	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	46883	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3697	usd
CY2024Q1	dei	Document Type DocumentType	20-F
CY2024Q1	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	19th Floor, 885 West Georgia Street
CY2024Q1	dei	Entity Address Country EntityAddressCountry	CA
CY2024Q1	dei	Auditor Name AuditorName	DAVIDSON & COMPANY LLP
CY2024Q1	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	592613	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	84871	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	108233	usd
CY2024Q1	cxxif	Current Deferred Tax Liabilities CurrentDeferredTaxLiabilities	15965	usd
CY2024Q1	us-gaap	Liabilities Liabilities	24252424	usd
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120047814
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120047814
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120047814
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	105467920	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	105467920	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2271248	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2272056	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72851401	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72776997	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	30973412	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	31047008	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55225836	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54528934	usd
CY2024	us-gaap	Revenues Revenues	28285200	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	2688650	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	17135434	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1776300	usd
CY2024	us-gaap	Gross Profit GrossProfit	11149766	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1486394	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9677738	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	289906	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	1472028	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	22189	usd
CY2024	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-451372	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-11655	usd
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1202227	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-74404	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3305285	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	808	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15089	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3290196	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	31047008	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-137807	usd
CY2024	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	249071	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	207225	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1408976	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5788	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	22189	usd
CY2024	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	503544	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-11655	usd
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1202227	usd
CY2024Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-7591	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<div> <div> <div> <p style="text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1.</strong><span style="width:10.49pt;display:inline-block"> </span><strong>NATURE OF OPERATIONS </strong></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C21 Investments Inc. (the "Company" or "C21") was incorporated on January 15, 1987, under the Company Act of British Columbia. The Company is a publicly traded company with its registered office is 170-601 West Cordova Street, Vancouver, BC, V6B 1G1. The Company is listed on the Canadian Securities Exchange under the symbol CXXI and on the OTCQB® Venture Market under the symbol CXXIF.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is a cannabis operator in Nevada, USA and is engaged in the cultivation of and manufacturing of cannabis flower products, vape products and extract products for wholesale and retail sales. The Company initially also had operations in the state of Oregon. During the year ended January 31, 2022, the Company made a strategic decision to cease operations in Oregon. The results of the Company's Oregon operations are presented as discontinued operations.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at March 31, 2024, the Company had a working capital deficit of $6,908,835 (January 31, 2024 - $6,922,786) and an accumulated deficit of $72,851,401 (January 31, 2024 - $72,776,997). However, for the years ended March 31, 2024 and January 31, 2024, the Company generated positive operating cash flows from continuing operations.</span></span></p> <p style="text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At the federal level, cannabis currently remains a Schedule I controlled substance under the Federal Controlled Substances Act of 1970. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of accepted safety for the use of the drug under medical supervision. As such, even in those states in which marijuana is legalized under state law, the manufacture, importation, possession, use or distribution of cannabis remains illegal under U.S. federal law. This has created a dichotomy between state and federal law, whereby many states have elected to regulate and remove state-level penalties regarding a substance which is still illegal at the federal level. There remains uncertainty about the US federal government's position on cannabis with respect to cannabis-legal status. A change in its enforcement policies could impact the ability of the Company to continue as a going concern.</span></span></p> </div> </div> </div>
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72851401	usd
CY2024Q1	cxxif	Fdic Coverage Over Cash Balance FdicCoverageOverCashBalance	876783	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1156259	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3482125	usd
CY2024Q1	us-gaap	Revenue Recognition Loyalty Programs RevenueRecognitionLoyaltyPrograms	<div> <p style="text-align:justify;margin-left:18pt;text-indent:-18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>r)</strong><span style="width:11.5pt;text-indent:0pt;display:inline-block"> </span><strong>Loyalty program</strong></span></span></p> <p style="text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company offers a loyalty reward program to its dispensary customers that allows customers to earn reward credits that can be applied to future purchases. Loyalty reward credits issued as part of a sales transaction result in revenue being deferred until the loyalty reward is redeemed by the customer. The loyalty rewards are shown as reductions to the 'Revenue' line within the accompanying consolidated statements of income and comprehensive income and included as deferred revenue on the consolidated balance sheets. A portion of the revenue generated in a sale must be allocated to the loyalty points earned. The amount allocated to the points earned is deferred until the loyalty points are redeemed or expire. The loyalty program expiration policy is six months. As of March 31, 2024 and January 31, 2024, the loyalty liability totaled $287,560 and $301,562, respectively, and is included in deferred revenue on the consolidated balance sheets.</span></span></p> </div>
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5346130	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5294647	usd
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1202227	usd
CY2024Q1	cxxif	Finite Lived Brands Gross FiniteLivedBrandsGross	644800	usd
CY2024Q1	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	1540447	usd
CY2024Q1	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	1540447	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6286590	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6482865	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	50285	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	67367	cad
CY2024Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	0	usd
CY2024Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	0	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1486918	usd
CY2024Q1	cxxif	Remaining Earn Out Share Obligation RemainingEarnOutShareObligation	1207200
CY2024Q1	cxxif	Remaining Number Of Shares To Be Delivered RemainingNumberOfSharesToBeDelivered	1184407
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.18
CY2023	cxxif	Weighted Average Remaining Life Of Warrants Outstanding WeightedAverageRemainingLifeOfWarrantsOutstanding	P1Y1M6D
CY2024	cxxif	Number Of Warrants Expired NumberOfWarrantsExpired	2040000
CY2024	cxxif	Weighted Average Exercise Price Of Warrants Expired WeightedAverageExercisePriceOfWarrantsExpired	1
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1200000
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.5
CY2024	cxxif	Weighted Average Remaining Life Of Warrants Outstanding WeightedAverageRemainingLifeOfWarrantsOutstanding	P0Y3M21D
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1200000
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.5
CY2024Q1	cxxif	Weighted Average Remaining Life Of Warrants Outstanding WeightedAverageRemainingLifeOfWarrantsOutstanding	P0Y1M24D
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1200000
CY2024Q1	cxxif	Warrants Outstanding And Exercisable Intrinsic Value WarrantsOutstandingAndExercisableIntrinsicValue	0	usd
CY2024Q1	cxxif	Warrants Outstanding And Exercisable Intrinsic Value WarrantsOutstandingAndExercisableIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.7
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1405000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.25
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3710000
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.73
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1100000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y8M15D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1100000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1100000
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	1133964	usd
CY2024Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	1399538	usd
CY2024Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	1440158	usd
CY2024Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	1481996	usd
CY2024Q1	us-gaap	Other Commitment OtherCommitment	13490801	usd
CY2024Q1	cxxif	Salary Paid To Directors And Officers SalaryPaidToDirectorsAndOfficers	92420	usd
CY2024Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	287638	usd
CY2024	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3804733	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-51439	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3223468	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-74404	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3305285	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q1	cxxif	Interest Rate On Unpaid Judgment InterestRateOnUnpaidJudgment	0.09	pure
CY2024Q2	us-gaap	Legal Fees LegalFees	108876	usd
CY2024Q1	cxxif	Deferred Tax Assets Rightof Use Assets And Lease Liabilities Net DeferredTaxAssetsRightofUseAssetsAndLeaseLiabilitiesNet	1048101	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5261352	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	46883	usd
CY2024Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	47015	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	-91186	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	789112	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5059	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	usd
CY2024	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	171314	usd
CY2024	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	714043	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	-94883	usd
CY2024Q1	cxxif	Description Of Corporate Minimum Tax On Large Corporations DescriptionOfCorporateMinimumTaxOnLargeCorporations	For taxable years beginning after December 31, 2022, the Act creates a 15% corporate minimum tax on large corporations with more than $1 billion in financial statement net income, and a 1% excise tax on stock buybacks.
CY2024Q1	dei	Auditor Firm AuditorFirmId	731
CY2024Q1	us-gaap	Cash Cash	2408526	usd
CY2023Q1	us-gaap	Cash Cash	1891772	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	203021	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	412310	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2708721	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4173573	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	751139	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	881628	usd
CY2024Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	1170947	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	1240011	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	7242354	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	8599294	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3433094	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4685118	usd
CY2024Q1	cxxif	Right Of Use Asset Current RightOfUseAssetCurrent	8829298	usd
CY2023Q1	cxxif	Right Of Use Asset Current RightOfUseAssetCurrent	8385533	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6482865	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7886825	usd
CY2024Q1	us-gaap	Goodwill Goodwill	28541323	usd
CY2023Q1	us-gaap	Goodwill Goodwill	28541323	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	46871	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	166440	usd
CY2024Q1	us-gaap	Assets Assets	54528934	usd
CY2023Q1	us-gaap	Assets Assets	58311404	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2215956	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2921426	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1156259	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1156259	usd
CY2024Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	0	usd
CY2023Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	2026667	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	9719872	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	7736858	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	301562	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	94068	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	374548	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	398723	usd
CY2024Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	396943	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	640266	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14165140	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14974267	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9192588	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8554702	usd
CY2024Q1	us-gaap	Lease Deposit Liability LeaseDepositLiability	0	usd
CY2023Q1	us-gaap	Lease Deposit Liability LeaseDepositLiability	175000	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	108233	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	239700	usd
CY2024Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	0	usd
CY2023Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	52659	usd
CY2024Q1	cxxif	Current Deferred Tax Liabilities CurrentDeferredTaxLiabilities	15965	usd
CY2023Q1	cxxif	Current Deferred Tax Liabilities CurrentDeferredTaxLiabilities	0	usd
CY2024Q1	us-gaap	Liabilities Liabilities	23481926	usd
CY2023Q1	us-gaap	Liabilities Liabilities	23996328	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120047814
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120047814
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120047814
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120047814
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	105467920	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	105445792	usd
CY2024Q1	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	628141	usd
CY2023Q1	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	628141	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2272056	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2287145	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72776997	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69471712	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	31047008	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	34315076	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54528934	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58311404	usd
CY2024	us-gaap	Revenues Revenues	28285200	usd
CY2023	us-gaap	Revenues Revenues	28888410	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	17135434	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	15487264	usd
CY2024	us-gaap	Gross Profit GrossProfit	11149766	usd
CY2023	us-gaap	Gross Profit GrossProfit	13401146	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9677738	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9445908	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	1472028	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	3955238	usd
CY2024	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-451372	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	742483	usd
CY2024	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	503544	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-11655	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1202227	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20726	usd
CY2024	us-gaap	Interest Expense InterestExpense	35210	usd
CY2023	us-gaap	Interest Expense InterestExpense	456691	usd
CY2024	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-16451	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-28996	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258657	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4191308	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3482125	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2809768	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3223468	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1381540	usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-81817	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1088329	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3305285	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	293211	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15089	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	83822	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3290196	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	377033	usd
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.01
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.01
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120047814
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120047814
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122880907
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122880907
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	33728602	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	209441	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	377033	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	34315076	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22128	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3290196	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	31047008	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3223468	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1381540	usd
CY2024	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	480340	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	490351	usd
CY2024	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	249071	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-56920	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1408976	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1843366	usd
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5788	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	21670	usd
CY2024	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-451372	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	742483	usd
CY2024	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	503544	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-11655	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1202227	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20726	usd
CY2024	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	35210	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	456360	usd
CY2024	cxxif	Provision To Record Inventory At Net Realizable Value ProvisionToRecordInventoryAtNetRealizableValue	0	usd
CY2023	cxxif	Provision To Record Inventory At Net Realizable Value ProvisionToRecordInventoryAtNetRealizableValue	174453	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	22128	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	209441	usd
CY2024	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-209289	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	201887	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1948095	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	293553	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-130489	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	108178	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1034911	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	184662	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1983014	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2866688	usd
CY2024	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	207494	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	94068	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-310394	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-325697	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3261255	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	5971267	usd
CY2024	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	68599	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-71292	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	521579	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	442285	usd
CY2024	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	400000	usd
CY2023	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	0	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-121579	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-442285	usd
CY2024	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	51357	usd
CY2024	cxxif	Payments For Settlement Of Earn Out Shares PaymentsForSettlementOfEarnOutShares	575136	usd
CY2023	cxxif	Payments For Settlement Of Earn Out Shares PaymentsForSettlementOfEarnOutShares	0	usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2026667	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6080000	usd
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	40000	usd
CY2024	cxxif	Interest Paid In Cash InterestPaidInCash	51562	usd
CY2023	cxxif	Interest Paid In Cash InterestPaidInCash	505747	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2653365	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-6625747	usd
CY2024	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-45551	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-58150	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7395	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1361	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	516754	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1176211	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1891772	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3067983	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2408526	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1891772	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	1250150	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	51562	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	505747	usd
CY2024	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	924105	usd
CY2023	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	0	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<div> <p style="text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1.</strong><span style="width:10.49pt;display:inline-block"> </span><strong>NATURE OF OPERATIONS </strong></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C21 Investments Inc. (the "Company" or "C21") was incorporated January 15, 1987, under the Company Act of British Columbia. The Company is a publicly traded company with its registered office is 170-601 West Cordova Street, Vancouver, BC, V6B 1G1. The Company is listed on the Canadian Securities Exchange under the symbol CXXI and on the OTCQB® Venture Market under the symbol CXXIF.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is a cannabis operator in Nevada, USA and is engaged in the cultivation of and manufacturing of cannabis flower products, vape products and extract products for wholesale and retail sales. The Company initially also had operations in the state of Oregon. During the year ended January 31, 2022, the Company made a strategic decision to cease operations in Oregon. The results of the Company's Oregon operations are presented as discontinued operations.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at January 31, 2024, the Company had a working capital deficiency of $6,922,786 (January 31, 2023 - $6,374,973) and an accumulated deficit of $72,776,997 (January 31, 2023 - $69,471,712). However, for the years ended January 31, 2024 and 2023, the Company generated positive operating cash flows from continuing operations.</span></span></p> <p style="text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At the federal level, cannabis currently remains a Schedule I controlled substance under the Federal Controlled Substances Act of 1970. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of accepted safety for the use of the drug under medical supervision. As such, even in those states in which marijuana is legalized under state law, the manufacture, importation, possession, use or distribution of cannabis remains illegal under U.S. federal law. This has created a dichotomy between state and federal law, whereby many states have elected to regulate and remove state-level penalties regarding a substance which is still illegal at the federal level. There remains uncertainty about the US federal government's position on cannabis with respect to cannabis-legal status. A change in its enforcement policies could impact the ability of the Company to continue as a going concern.</span></span></p> </div>
CY2024Q1	cxxif	Working Capital Deficit WorkingCapitalDeficit	-6922786	usd
CY2023Q1	cxxif	Working Capital Deficit WorkingCapitalDeficit	-6374973	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72776997	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69471712	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Deferred Tax Assets DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets	143078	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="text-align:justify;margin-left:18pt;text-indent:-18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>a)</strong><span style="width:10pt;text-indent:0pt;display:inline-block"> </span><strong>Significant accounting estimates and assumptions</strong></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the Company's consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities and contingent liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and assumptions are continuously evaluated and are based on management's experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from those estimates and judgments.</span></span></p> <p style="text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Areas requiring a significant degree of estimation and judgment relate to the determination of recoverability of goodwill, recoverability of intangible assets, fair value less costs to sell of assets classified as held for sale, estimates used in valuation and costing of inventory, impairment of long-lived assets and inventory, fair value measurements, useful lives, depreciation and amortization of property, equipment and intangible assets, the recoverability and measurement of deferred tax assets and liabilities, share-based compensation, and fair value of derivative liability.</span></span></p> </div>
CY2024Q1	cxxif	Fdic Coverage Over Cash Balance FdicCoverageOverCashBalance	965157	usd
CY2023Q1	cxxif	Fdic Coverage Over Cash Balance FdicCoverageOverCashBalance	697945	usd
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2024Q1	cxxif	Working Capital Deficit WorkingCapitalDeficit	-6922786	usd
CY2023Q1	cxxif	Working Capital Deficit WorkingCapitalDeficit	-6374973	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	9719872	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3482125	usd
CY2024	us-gaap	Revenue Recognition Loyalty Programs RevenueRecognitionLoyaltyPrograms	<div> <p style="text-align:justify;margin-left:18pt;text-indent:-18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>r)</strong><span style="width:11.5pt;text-indent:0pt;display:inline-block"> </span><strong>Loyalty program</strong></span></span></p> <p style="text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company offers a loyalty reward program to its dispensary customers that allows customers to earn reward credits that can be applied to future purchases. Loyalty reward credits issued as part of a sales transaction result in revenue being deferred until the loyalty reward is redeemed by the customer. The loyalty rewards are shown as reductions to the 'Revenue' line within the accompanying consolidated statements of income and comprehensive income and included as deferred revenue on the consolidated balance sheets. A portion of the revenue generated in a sale must be allocated to the loyalty points earned. The amount allocated to the points earned is deferred until the loyalty points are redeemed or expire. The loyalty program expiration policy is six months. As of January 31, 2024 and 2023, the loyalty liability totaled $301,562 and $94,068, respectively, and is included in deferred revenue on the consolidated balance sheets.</span></span></p> </div>
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	301562	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	94068	usd
CY2024	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	68599	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-71292	usd
CY2024	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	51357	usd
CY2024	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-45551	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-58150	usd
CY2024Q1	cxxif	Sales Taxes Receivable SalesTaxesReceivable	13829	usd
CY2023Q1	cxxif	Sales Taxes Receivable SalesTaxesReceivable	10834	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	189192	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	401476	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	203021	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	412310	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1421541	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1556353	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1139116	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2494455	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	148064	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	122765	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2708721	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4173573	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5294647	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6032170	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1861553	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1347052	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3433094	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4685118	usd
CY2024	us-gaap	Depreciation Depreciation	559712	usd
CY2023	us-gaap	Depreciation Depreciation	533702	usd
CY2024	cxxif	Depreciation And Amortization Expense Allocated To Inventory DepreciationAndAmortizationExpenseAllocatedToInventory	474172	usd
CY2023	cxxif	Depreciation And Amortization Expense Allocated To Inventory DepreciationAndAmortizationExpenseAllocatedToInventory	472096	usd
CY2024	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	372227	usd
CY2023	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	20726	usd
CY2024	cxxif	Impairment Loss On Land ImpairmentLossOnLand	830000	usd
CY2024Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	12010274	usd
CY2023Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	12167021	usd
CY2024Q1	cxxif	Finite Lived Brands Gross FiniteLivedBrandsGross	644800	usd
CY2023Q1	cxxif	Finite Lived Brands Gross FiniteLivedBrandsGross	644800	usd
CY2024Q1	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	1540447	usd
CY2023Q1	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	1540447	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14195521	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14352268	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7712656	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6465443	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6482865	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7886825	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1332507	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1337336	usd
CY2024	cxxif	Amortization Of Intangible Assets Allocated To Inventory AmortizationOfIntangibleAssetsAllocatedToInventory	9071	usd
CY2023	cxxif	Amortization Of Intangible Assets Allocated To Inventory AmortizationOfIntangibleAssetsAllocatedToInventory	9065	usd
CY2024	cxxif	Cost Value Of Licenses Disposed CostValueOfLicensesDisposed	156750	usd
CY2024	cxxif	Accumulated Amortization Of Licenses Disposed AccumulatedAmortizationOfLicensesDisposed	85294	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1298974	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1298974	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1298974	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1298974	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1286969	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6482865	usd
CY2024Q1	us-gaap	Goodwill Goodwill	28541323	usd
CY2023Q1	us-gaap	Goodwill Goodwill	28541323	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	50285	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	67367	cad
CY2024Q1	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	52474	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	70300	cad
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2189	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2933	cad
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	0	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	46871	usd
CY2024Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	0	usd
CY2023Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	52659	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1188133	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1842089	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	415323	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	450485	usd
CY2024Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	612500	usd
CY2023Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	612500	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	16352	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2215956	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2921426	usd
CY2024	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	35210	usd
CY2023	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	455091	usd
CY2024	cxxif	Interest Payment In Cash InterestPaymentInCash	51562	usd
CY2023	cxxif	Interest Payment In Cash InterestPaymentInCash	504147	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	1446208	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1403743	usd
CY2024	cxxif	Portion Of Operating Lease Costs Allocated To Inventory PortionOfOperatingLeaseCostsAllocatedToInventory	812368	usd
CY2023	cxxif	Portion Of Operating Lease Costs Allocated To Inventory PortionOfOperatingLeaseCostsAllocatedToInventory	812368	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y9M7D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7M17D
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1314551	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1353987	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1394607	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1436445	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	10718831	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	16218421	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6651285	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	9567136	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	374548	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9192588	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	16218421	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14488346	usd
CY2024Q1	cxxif	Undiscounted Lease Liabilities Classified As Held For Sale UndiscountedLeaseLiabilitiesClassifiedAsHeldForSale	0	usd
CY2023Q1	cxxif	Undiscounted Lease Liabilities Classified As Held For Sale UndiscountedLeaseLiabilitiesClassifiedAsHeldForSale	228192	usd
CY2023Q1	cxxif	Obligation To Issue Shares Settled Number Of Shares ObligationToIssueSharesSettledNumberOfShares	4792800
CY2023Q1	cxxif	Payments For Settlement Of Earn Out Shares PaymentsForSettlementOfEarnOutShares	575136	usd
CY2024Q1	cxxif	Remaining Earn Out Share Obligation RemainingEarnOutShareObligation	1207200
CY2023Q1	cxxif	Remaining Earn Out Share Obligation RemainingEarnOutShareObligation	6000000
CY2018Q2	cxxif	Number Of Shares Issued To Vendors NumberOfSharesIssuedToVendors	1977500
CY2018Q2	cxxif	Value Of Shares Issued To Vendors ValueOfSharesIssuedToVendors	1905635	usd
CY2024Q1	cxxif	Remaining Number Of Shares To Be Delivered RemainingNumberOfSharesToBeDelivered	1184407
CY2023Q1	cxxif	Remaining Number Of Shares To Be Delivered RemainingNumberOfSharesToBeDelivered	1184407
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3240000
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.18
CY2022	cxxif	Weighted Average Remaining Life Of Warrants Outstanding WeightedAverageRemainingLifeOfWarrantsOutstanding	P2Y1M6D
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3240000
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.18
CY2023	cxxif	Weighted Average Remaining Life Of Warrants Outstanding WeightedAverageRemainingLifeOfWarrantsOutstanding	P1Y1M6D
CY2024	cxxif	Number Of Warrants Expired NumberOfWarrantsExpired	2040000
CY2024	cxxif	Weighted Average Exercise Price Of Warrants Expired WeightedAverageExercisePriceOfWarrantsExpired	1
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1200000
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.5
CY2024	cxxif	Weighted Average Remaining Life Of Warrants Outstanding WeightedAverageRemainingLifeOfWarrantsOutstanding	P0Y3M21D
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1200000
CY2024Q1	cxxif	Warrants Outstanding And Exercisable Intrinsic Value WarrantsOutstandingAndExercisableIntrinsicValue	0	usd
CY2023Q1	cxxif	Warrants Outstanding And Exercisable Intrinsic Value WarrantsOutstandingAndExercisableIntrinsicValue	0	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5615000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M12D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	600000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.7
CY2023	cxxif	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P2Y10D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1405000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.25
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4810000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M9D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3710000
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.73
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1100000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M17D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1100000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	899999
CY2024Q1	cxxif	Stock Options Outstanding And Exercisable Intrinsic Value StockOptionsOutstandingAndExercisableIntrinsicValue	0	usd
CY2023Q1	cxxif	Stock Options Outstanding And Exercisable Intrinsic Value StockOptionsOutstandingAndExercisableIntrinsicValue	0	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	22128	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	209441	usd
CY2024Q1	us-gaap	Share Price SharePrice	0.61
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.7
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016	pure
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.80	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024	us-gaap	Legal Fees LegalFees	892733	usd
CY2023	us-gaap	Legal Fees LegalFees	716349	usd
CY2024	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1408976	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1365018	usd
CY2024	cxxif	License Fees Taxes And Insurance LicenseFeesTaxesAndInsurance	1603921	usd
CY2023	cxxif	License Fees Taxes And Insurance LicenseFeesTaxesAndInsurance	1625036	usd
CY2024	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	384583	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	338492	usd
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	633840	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	591375	usd
CY2024	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	907918	usd
CY2023	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	806009	usd
CY2024	us-gaap	Professional Fees ProfessionalFees	522900	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	903513	usd
CY2024	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3156441	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2747133	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	75561	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	83672	usd
CY2024	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	22128	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	209441	usd
CY2024	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	16523	usd
CY2023	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	18128	usd
CY2024	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	52214	usd
CY2023	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	41742	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9677738	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9445908	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	12262392	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	13070651	usd
CY2024Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	1360101	usd
CY2024Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	1399538	usd
CY2024Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	1440158	usd
CY2024Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	1481996	usd
CY2024Q1	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	8035144	usd
CY2024Q1	us-gaap	Other Commitment OtherCommitment	13716937	usd
CY2024	cxxif	Consulting Fees Paid To Director ConsultingFeesPaidToDirector	65000	usd
CY2023	cxxif	Consulting Fees Paid To Director ConsultingFeesPaidToDirector	125000	usd
CY2024	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Leases AmountsPaidToCeoOrCompaniesControlledByCeoForLeases	1001214	usd
CY2023	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Leases AmountsPaidToCeoOrCompaniesControlledByCeoForLeases	1239090	usd
CY2024	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Repayments Of Promissory Note AmountsPaidToCeoOrCompaniesControlledByCeoForRepaymentsOfPromissoryNote	2078229	usd
CY2023	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Repayments Of Promissory Note AmountsPaidToCeoOrCompaniesControlledByCeoForRepaymentsOfPromissoryNote	6584146	usd
CY2024	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Remuneration AmountsPaidToCeoOrCompaniesControlledByCeoForRemuneration	200000	usd
CY2023	cxxif	Amounts Paid To Ceo Or Companies Controlled By Ceo For Remuneration AmountsPaidToCeoOrCompaniesControlledByCeoForRemuneration	200000	usd
CY2024	cxxif	Salary Paid To Directors And Officers SalaryPaidToDirectorsAndOfficers	438162	usd
CY2023	cxxif	Salary Paid To Directors And Officers SalaryPaidToDirectorsAndOfficers	398950	usd
CY2024	cxxif	Share Compensation For Directors And Officers ShareCompensationForDirectorsAndOfficers	22128	usd
CY2023	cxxif	Share Compensation For Directors And Officers ShareCompensationForDirectorsAndOfficers	153426	usd
CY2024	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3804733	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8700612	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3223468	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1381540	usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-81817	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1088329	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3305285	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	293211	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120047814
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120047814
CY2024	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2833093
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2833093
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122880907
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122880907
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.01
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.01
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div> <div> <div> <div> <div> <p style="text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>20.</strong><span style="width:5.49pt;display:inline-block"> </span><strong>CONTINGENCIES</strong></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">From time to time, the Company is involved in various litigation matters arising in the ordinary course of its business. Management is of the opinion that disposition of any current matter will not have a material adverse impact on the Company's financial position, results of operations, or the ability to carry on any of its business activities.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Legal proceedings </strong></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Oregon Action</strong>: A complaint was filed in the Oregon State Circuit Court for Clackamas County, on April 29, 2019, by two current owners of Proudest Monkey Holdings, LLC (the former sole member of EFF) (the "Plaintiffs"), alleging contract, employment, and statutory claims, alleging $612,500 in damages (as amended), against the Company, its wholly-owned subsidiaries 320204 US Holdings Corp, EFF, Swell Companies Limited, and Phantom Brands LLC, in addition to three directors, two officers, and one former employee (the "Oregon Action"). The Company and the other defendants wholly denied the allegations and claims made in the lawsuit and is defending the lawsuit. On June 21, 2019, the Company filed Oregon Rule of Civil Procedure ("ORCP") 21 motions to dismiss all of the Plaintiffs' claims against it, its wholly owned subsidiaries, and other defendants. On December 30, 2019, the Plaintiffs filed an amended complaint dismissing the Company (and some of its directors and subsidiaries) from the case and reducing the amount in controversy in the Oregon Action. On May 6, 2020, the court granted the Company's ORCP 21 motions in its entirety to dismiss all of Plaintiffs' claims against the remaining defendants. The judgment of dismissal was entered by the Clackamas County court on or about October 14, 2020.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 22, 2020, the Company submitted a petition to recover the costs and attorney fees incurred by the Company as the prevailing party in the Oregon Action. On January 20, 2021, the Court ruled in the Company's favor, awarding the Company and its subsidiaries $68,195 in attorney's fees, $1,252 in costs, and a statutory prevailing party fee of $640, through a supplemental judgment, entered on February 2, 2021. The judgment in favor of the Company remains unpaid and continues to collect interest at the statutory rate of 9% per annum.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 12, 2020, the Plaintiffs appealed the order dismissing the claims alleged in their amended complaint. On March 2, 2021, the Plaintiffs amended their appeal to appeal the award of attorney fees and costs.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 26, 2022, the Court of Appeals issued its decision, reversing the general and supplemental judgments in favor of the Company and remanding the case to the trial court for further proceedings. The Company filed a petition for reconsideration of the Court of Appeals decision on December 7, 2022, which was denied. On April 19, 2023, the Company filed a petition for review in the Oregon Supreme Court, which was denied. On November 1, 2023, the Court of Appeals issued the appellate judgement that reversed the October 2023 dismissal as well as the judgement for attorney fees and remanded the case against Phantom Brands, LLC, Swell Companies Limited, and two former employees. On December 21, 2023, the Plaintiffs filed a second amended complaint.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 2, 2024, the court confirmed dismissal of the Company and other defendants no longer named. <span style="background-color:transparent">The Company has filed a motion for costs and attorney fees totaling $108,876, with a hearing scheduled for July 29, 2024. Additionally, a settlement conference is set for October 22, 2024, and a twelve-person jury trial is scheduled for November 19, 2024.</span></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>British Columbia Action</strong>: On or about September 13, 2019, the Company delivered a notice to the above-mentioned Plaintiffs of alleged breach and default under the EFF purchase and sale agreement, due to alleged unlawful, intentional acts and material misrepresentations by the Plaintiffs before and after the completion of the purchase. As a result of such breach, the Company denied the Plaintiffs' tender of their share payment notes in connection with the agreement. On or about October 14, 2019, Proudest Monkey Holdings, LLC and one of its current owners, sued the Company in the Supreme Court of British Columbia to compel the issuance and delivery of the subject shares, including interests and costs (the "British Columbia Action").</span></span></p> <div></div> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 8, 2019, the Company responded and counterclaimed for general, special and punitive damages, including interest and costs, related to breach of contract, repudiation of contract, breach of indemnity and fraudulent and negligent misrepresentation by the Plaintiffs. The Plaintiffs filed a response to the Company's counterclaims on or about June 5, 2020, and the parties stipulated to a form of amended pleading which included the joinder of additional parties, an owner of Proudest Monkey Holdings, LLC and EFF, and additional contract and equitable claims and damages, partially duplicative to those alleged by the Plaintiffs in the Oregon Action (breach of contract, indemnity, unjust enrichment and wrongful termination claims). Plaintiffs allege $2,774,177 in damages (as amended), plus unquantified additional damages, interest and costs, of which amounts are partially duplicative of the Oregon Action. This action remains in the discovery stage. The trial date was removed due to lack of prosecution by Plaintiffs. It is too early to predict the resolution of the claims and counterclaims.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Settled and Dismissed Action</strong>: On or about May 30, 2019, Wallace Hill Partners Ltd. ("Wallace Hill") filed a civil claim in the Supreme Court of British Columbia alleging breach of contract and entitlement to 1,800,000 Common Shares of the Company, fully vested by March 1, 2019, and damages due to the lost opportunity to sell those shares after such date for a profit. On June 23, 2019, the Company circulated a letter to Wallace Hill terminating the agreement and accepting Wallace Hill's repudiation of the agreement based on Wallace Hill's previously published defamatory comments and termination of the agreement. On June 23, 2019, the Company filed its response to the civil claim denying all claims and filed counterclaims alleging breach of contract, a declaratory judgment of termination of the agreement, defamation and an injunction from further defamatory comments.</span></span></p> <p style="text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 23, 2022, the Company and Wallace Hill entered into a mutual release agreement, pursuant to which, among other things, all parties agreed to dismiss their respective claims and to release one another from any further causes of action in connection with the subject matter of the original claims. On April 23, 2022, the parties filed a Notice of Discontinuance in the Supreme Court of British Columbia formally dismissing the civil action.</span></span></p> </div> </div> </div> </div> </div>
CY2021Q1	us-gaap	Legal Fees LegalFees	68195	usd
CY2021Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1252	usd
CY2021Q1	cxxif	Statutory Prevailing Party Fee StatutoryPrevailingPartyFee	640	usd
CY2021Q1	cxxif	Interest Rate On Unpaid Judgment InterestRateOnUnpaidJudgment	0.09	pure
CY2024Q2	us-gaap	Legal Fees LegalFees	108876	usd
CY2019Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2774177	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3233053	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2866688	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	249072	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-56920	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3482125	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2809768	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258657	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4191308	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258657	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4191308	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-74152	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1131653	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Irc Section280 E Disallowance EffectiveIncomeTaxRateReconciliationIrcSection280EDisallowance	1954392	usd
CY2023	cxxif	Effective Income Tax Rate Reconciliation Irc Section280 E Disallowance EffectiveIncomeTaxRateReconciliationIrcSection280EDisallowance	1802992	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	16068	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-288933	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Change In Foreign Exchange Rates And Other EffectiveIncomeTaxRateReconciliationChangeInForeignExchangeRatesAndOther	21188	usd
CY2023	cxxif	Effective Income Tax Rate Reconciliation Change In Foreign Exchange Rates And Other EffectiveIncomeTaxRateReconciliationChangeInForeignExchangeRatesAndOther	196298	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Uncertain Tax Position Inclusive Of Interest And Penalties EffectiveIncomeTaxRateReconciliationUncertainTaxPositionInclusiveOfInterestAndPenalties	-354637	usd
CY2023	cxxif	Effective Income Tax Rate Reconciliation Uncertain Tax Position Inclusive Of Interest And Penalties EffectiveIncomeTaxRateReconciliationUncertainTaxPositionInclusiveOfInterestAndPenalties	32591	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-50016	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-198848	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Payable Adjustment To Provision Versus Statutory Tax Returns EffectiveIncomeTaxRateReconciliationPayableAdjustmentToProvisionVersusStatutoryTaxReturns	1153756	usd
CY2023	cxxif	Effective Income Tax Rate Reconciliation Payable Adjustment To Provision Versus Statutory Tax Returns EffectiveIncomeTaxRateReconciliationPayableAdjustmentToProvisionVersusStatutoryTaxReturns	67056	usd
CY2024	cxxif	Effective Income Tax Rate Reconciliation Deferred Adjustment To Provision Versus Statutory Tax Returns EffectiveIncomeTaxRateReconciliationDeferredAdjustmentToProvisionVersusStatutoryTaxReturns	824220	usd
CY2023	cxxif	Effective Income Tax Rate Reconciliation Deferred Adjustment To Provision Versus Statutory Tax Returns EffectiveIncomeTaxRateReconciliationDeferredAdjustmentToProvisionVersusStatutoryTaxReturns	10410	usd
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-8694	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	56549	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3482125	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2809768	usd
CY2024Q1	cxxif	Deferred Tax Assets Share Issuance Costs And Financing Fees DeferredTaxAssetsShareIssuanceCostsAndFinancingFees	1610	usd
CY2023Q1	cxxif	Deferred Tax Assets Share Issuance Costs And Financing Fees DeferredTaxAssetsShareIssuanceCostsAndFinancingFees	4764	usd
CY2024Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	132394	usd
CY2023Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	132986	usd
CY2024Q1	cxxif	Deferred Tax Assets Non Capital Losses DeferredTaxAssetsNonCapitalLosses	5170743	usd
CY2023Q1	cxxif	Deferred Tax Assets Non Capital Losses DeferredTaxAssetsNonCapitalLosses	4704180	usd
CY2024Q1	cxxif	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	82004	usd
CY2023Q1	cxxif	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	230563	usd
CY2024Q1	cxxif	Deferred Tax Assets Goodwill DeferredTaxAssetsGoodwill	6606	usd
CY2023Q1	cxxif	Deferred Tax Assets Goodwill DeferredTaxAssetsGoodwill	0	usd
CY2024Q1	cxxif	Deferred Tax Assets Rightof Use Assets And Lease Liabilities Net DeferredTaxAssetsRightofUseAssetsAndLeaseLiabilitiesNet	1048101	usd
CY2023Q1	cxxif	Deferred Tax Assets Rightof Use Assets And Lease Liabilities Net DeferredTaxAssetsRightofUseAssetsAndLeaseLiabilitiesNet	1095352	usd
CY2024Q1	cxxif	Deferred Tax Assets Reclamation Obligation DeferredTaxAssetsReclamationObligation	0	usd
CY2023Q1	cxxif	Deferred Tax Assets Reclamation Obligation DeferredTaxAssetsReclamationObligation	14219	usd
CY2024Q1	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	29223	usd
CY2023Q1	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	64719	usd
CY2024Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	36797	usd
CY2024Q1	cxxif	Deferred Tax Assets Convertible Promissory Note DeferredTaxAssetsConvertiblePromissoryNote	0	usd
CY2023Q1	cxxif	Deferred Tax Assets Convertible Promissory Note DeferredTaxAssetsConvertiblePromissoryNote	312190	usd
CY2024Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3686	usd
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	14187	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6488554	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6595770	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5261352	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5311368	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1227202	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1284402	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	95857	usd
CY2024Q1	cxxif	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	959509	usd
CY2023Q1	cxxif	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	1022105	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	283658	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1243167	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1117962	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-15965	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	166440	usd
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4604054	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	68530	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	68530	usd
CY2024Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	47015	usd
CY2024	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	20369	usd
CY2024	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	1012	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	789112	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	813855	usd
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5059	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2024	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	171314	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	usd
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2024	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	714043	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	24743	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	-91186	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	789112	usd
CY2024	cxxif	Description Of Corporate Minimum Tax On Large Corporations DescriptionOfCorporateMinimumTaxOnLargeCorporations	For taxable years beginning after December 31, 2022, the Act creates a 15% corporate minimum tax on large corporations with more than $1 billion in financial statement net income, and a 1% excise tax on stock buybacks.

Files In Submission

Name	View Source	Status
0001062993-24-014658-index-headers.html	Edgar Link	pending
0001062993-24-014658-index.html	Edgar Link	pending
0001062993-24-014658.txt	Edgar Link	pending
0001062993-24-014658-xbrl.zip	Edgar Link	pending
cxxif-20240331.xsd	Edgar Link	pending
exhibit12-1.htm	Edgar Link	pending
exhibit12-2.htm	Edgar Link	pending
exhibit13-1.htm	Edgar Link	pending
exhibit13-2.htm	Edgar Link	pending
exhibit15-1.htm	Edgar Link	pending
cxxif-20240331_cal.xml	Edgar Link	unprocessable
cxxif-20240331_lab.xml	Edgar Link	unprocessable
cxxif-20240331_def.xml	Edgar Link	unprocessable
exhibit15-1x001.jpg	Edgar Link	pending
exhibit15-1x002.jpg	Edgar Link	pending
exhibit15-1x003.jpg	Edgar Link	pending
exhibit15-2.htm	Edgar Link	pending
exhibit15-2xu001.jpg	Edgar Link	pending
exhibit15-2xu002.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form20f.htm	Edgar Link	pending
form20fxz001.jpg	Edgar Link	pending
form20fxz002.jpg	Edgar Link	pending
form20fxz003.jpg	Edgar Link	pending
form20fxz004.jpg	Edgar Link	pending
form20fxz005.jpg	Edgar Link	pending
form20fxz006.jpg	Edgar Link	pending
form20fxz007.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
form20f_htm.xml	Edgar Link	completed
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cxxif-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CXXIF
C21 Investments Inc. Stock $cxxif

2024 Q1 Form 20-F Financial Statement

#000106299324014658 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CXXIF C21 Investments Inc. Stock $cxxif

2024 Q1 Form 20-F Financial Statement

#000106299324014658 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CXXIF
C21 Investments Inc. Stock $cxxif